Sato, Tasuku
Fujino, Takeo
Higo, Taiki
Ohtani, Kisho
Hiasa, Ken-ichi
Shiose, Akira
Tsutsui, Hiroyuki
Funding for this research was provided by:
Japan Intractable Diseases (Nanbyo) Research Foundation
Article History
Received: 12 October 2018
Revised: 20 December 2018
Accepted: 24 January 2019
First Online: 6 February 2019
Compliance with ethical standards
:
: Hiroyuki Tsutsui received honoraria from Otsuka, Takeda Pharmaceutical, Mitsubishi-Tanabe Pharma, Daiichi Sankyo, Nippon Boehringer, Bayer Yakuhin, and Pfizer. Hiroyuki Tsutsui received manuscript fees from Igaku-shoin and Medical View. Hiroyuki Tsutsui received research funding from Nippon Boehringer and Mitsubishi-Tanabe Pharma. Tasuku Sato, Takeo Fujino, Taiki Higo, Kisho Ohtani, Ken-ichi Hiasa, and Akira Shiose declare that they have no conflict of interest.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later revisions.
: Informed consent was obtained from all patients for being included in the study.